Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-12

Clinical Trial Update: Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects [Phase 2]

View source ↗

Summary

Phase 2 dose-ranging study evaluating the salmeterol component of Fluticasone/Salmeterol Spiromax versus Fluticasone Spiromax and Advair Diskus in asthma; study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ADVAIR DISKUS (fluticasone propionate and salmeterol)
  • Fluticasone Spiromax (fluticasone propionate)
  • Fluticasone/Salmeterol Spiromax (fluticasone propionate and salmeterol)

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2017-04-12